Photo courtesy of OraPharma
Ora Pharma My Perio App Image 1 616ee90da6dca

First-of-its-kind patient education application for periodontal disease

Oct. 19, 2021
OraPharma introduces the MyPerioHealth app, an interactive oral health educational tool to help dental patients understand the stage and grade of their periodontal disease.

OraPharma, a leading oral care company of Bausch Health Companies Inc. (NYSE.TSX:BHC), today announced the US launch of the MyPerioHealth app, a first-of-its kind interactive oral health educational tool that offers patients, in conjunction with their dental professionals, a quick and easy way to understand the stage and grade of periodontal disease on a single, digital platform at the point of care.

“The MyPerioHealth education app was designed as a resource for dental professionals when using the Periodontal Staging and Grading Guidelines established by the American Academy of Periodontology (AAP) to help encourage dialogue and offer an interactive oral health assessment in a patient friendly, portable way,” said Dinesh Guglani, vice president and general manager of OraPharma. “By responding to a series of short questions, a patient and their dental care professional can obtain a wealth of important information regarding the patient’s periodontal health status, including the stage and grade, which are vital for treatment planning and determining the maintenance interval to help manage the disease.”

The AAP Guidelines are intended for patients who have already been diagnosed with periodontitis. The MyPerioHealth app complements manual staging and grading by streamlining data collection and automating calculations using the AAP guidelines. The app will help increase patients’ awareness of gum disease by encouraging dialogue and collaboration between dental professionals and their patients.

“The MyPerioHealth app will help enhance the understanding of periodontal disease by providing patients with the ability to have greater understanding and ownership of their disease. Armed with their periodontal score and the ramifications of unchecked periodontal disease, we believe patients will be more accepting of the treatment recommendations they receive from their doctors.” Guglani continued.

Designed for use on a tablet or cell phone, the MyPerioHealth app is available on both iOS and Android platforms. It can be downloaded from the Google Play Store, Apple App Store, or Amazon App Store. A web-based version can also be accessed at

About OraPharma

OraPharma, a leading oral care company of Bausch Health Companies Inc., is dedicated to developing innovative solutions in oral care to support dental health care professionals and patients. By focusing on improving patients’ lives through the connection between oral care and overall health, OraPharma offers a comprehensive suite of products that help address patients’ oral health concerns. These products include ARESTIN (minocycline HCl) Microspheres, 1 mg, NeutraSal (supersaturated calcium phosphate rinse), and XERESE (acyclovir and hydrocortisone) cream 5%/1%. For more information on OraPharma, visit

From a press release dated October 14, 2021